Arctic Bioscience AS
OSE:ABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
ShenZhen Special Economic Zone Real Estate & Properties Group Co Ltd
SZSE:000029
|
CN |
Arctic Bioscience AS
Net Income (Common)
Arctic Bioscience AS
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Arctic Bioscience AS
OSE:ABS
|
Net Income (Common)
-kr47.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Net Income (Common)
-kr94.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
Net Income (Common)
kr9.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Net Income (Common)
-$12.2m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Circio Holding ASA
OSE:CRNA
|
Net Income (Common)
-kr45.9m
|
CAGR 3-Years
53%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Net Income (Common)
-kr58m
|
CAGR 3-Years
49%
|
CAGR 5-Years
33%
|
CAGR 10-Years
1%
|
|
Arctic Bioscience AS
Glance View
Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The firm's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
See Also
What is Arctic Bioscience AS's Net Income (Common)?
Net Income (Common)
-47.9m
NOK
Based on the financial report for Dec 31, 2024, Arctic Bioscience AS's Net Income (Common) amounts to -47.9m NOK.
What is Arctic Bioscience AS's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-64%
Over the last year, the Net Income (Common) growth was -5%. The average annual Net Income (Common) growth rates for Arctic Bioscience AS have been -4% over the past three years , -64% over the past five years .
